Faron Pharmaceuticals Oy Share Discussion Threads

[elliotset] 15/4/2020 11:14

Support around £2.50 if it breaks that then £1.50

[soulected] 15/4/2020 10:41

They are my thoughts, trying to engage the conversation on the more active LSE, but no one seems to want to discuss. The volume is so low, so in the same way it can't really be seen as bad news coming either...

[daffodil4] 15/4/2020 10:20

Thoughts on drop??
Is is because SNG seems the
more likely treatment for Covid-19
using Interferon beta ?
I see their trial has been labelled urgent
by National Institue for Halth Research.
No volume here, whereas all other
drugs/tests related to Convid-19
are flying....

[daffodil4] 04/4/2020 13:46

Surprised we did not end higher..
I think the fact that the results are
due 2022 has maybe have held this back..
Wonder if they will still do the
trials as planned or will this
be the way forward....and not
need partner funding ..??
Great update on Clevegen but
not reflected in share price .very surprised..
may drift till further news...GLA!

[jojaken] 02/4/2020 04:56

Hugely encouraged by yesterday’s announcement that Faron was included in the REMAP-CAP program. Looking at the details the US was the only major region excluded from the REMAP-CAP program. Interestingly, a leading article in the NYT was looking at how own immune systems is the new area of focus in the battle against Covid-19. From the article it would appear that Tocilizumab is seen as an alternative candidate in the US. Could this be the start of a two way tussle between two similar, but different therapies?

For now this can only be good, as Traumakine gains traction as a lead therapy outside the US. Interesting times indeed!

hxxps://www.nytimes.com/2020/04/01/health/coronavirus-cytokine-storm-immune-system.html?action=click&module=Top%20Stories&pgtype=Homepage

[hashertu] 01/4/2020 15:14

This is potentially a very significant development.
Effectively a fast tracked trial, I assume open label, with a steroid only comparator.
Let's hope for a good outcome for all involved.

[daffodil4] 01/4/2020 10:08

bwgs

My post was on 30th March about Clevegen update..
so with today's RNS I am really surprised this
is not well over £6....possibly MM's at play
fairly small float...let's see where we close!
Hopefully Markuu will do the PR rounds..GL.

[bwgs] 01/4/2020 09:32

So did I Daffodil, any positive on the back of this though should motor us upwards.Market generally in the red today which doesn't help matters either. Great opportunity for FARN now

[toffeeman] 01/4/2020 08:51

Here as well BMNSA - I have a small holding as well (via Guinness AIM EIS)

[bmnsa] 01/4/2020 08:28

Better in than out:)

Just a small holding from £1.75.

[daffodil4] 30/3/2020 14:20

Fantastic RNS..thought this would fly today...!

[toffeeman] 26/3/2020 11:35

No idea - but it seems to be behind the most recent rise

[daffodil4] 26/3/2020 10:45

What do you guys think is the chance of a fast track for
Traumakine to treat Coronavirus?? On LSE
they seem to think it will...thoughts?? Thanks.

[toffeeman] 24/3/2020 09:18

At this rate that effing gap might close :)

[milliecusto] 23/3/2020 23:02

An earlier phase III trial missed its endpoints as therapeutic effect was affected by its use in a combination with cortical steroids.Faron, though, has just received approval from the US regulator to resubmit Traumakine for a new trial without these glucocorticoids.The company believes this will demonstrate a benefit in people affected by coronavirus and other viral infections.Markku Jalkanen, chief executive, believes Traumakine can be a potential first line of defence against the virus and critically for patients and health services boost ventilator-free days for those who lose respiratory capacity and need an external oxygen supply.Shares have shot ahead recently to 470p valuing the company at £200million.Admittedly, all are loss-making and none of the three will have a drug ready to go in the immediate future but as governments suggest the pandemic might last well into 2021 this look set to be a long battle.All 3 might be too late to the party

[soulected] 23/3/2020 21:22

Full article in Daily MailToday 19:11SMALL CAP SHARE IDEAS: AIM trio wade into battle against coronavirushtTps://mol.im/a/8143275

[soulected] 23/3/2020 21:22

Mentioned in Daily MailToday 19:07Faron Pharmaceutical's Traumakine is also an interferon-beta booster, but is intravenously administered and is targeting acute respiratory distress syndrome or ARDS, something that has become common among severely ill patients in the current coronavirus outbreak.An earlier phase III trial missed its endpoints as therapeutic effect was affected by its use in a combination with cortical steroids.Faron, though, has just received approval from the US regulator to resubmit Traumakine for a new trial without these glucocorticoids.The company believes this will demonstrate a benefit in people affected by coronavirus and other viral infections.Markku Jalkanen, chief executive, believes Traumakine can be a potential first line of defence against the virus and critically for patients and health services boost ventilator-free days for those who lose respiratory capacity and need an external oxygen supply.Shares have shot ahead recently to 470p valuing the company at £200million.

[tidy 2] 20/3/2020 08:34

More Spam you sad gutter boy.

[discojames] 19/3/2020 14:27

Better to follow the lse board for updates, but big news from Finland relating to Corona virus and faron

[jayminpatel1] 19/3/2020 14:01

SNG by far Biggest play out here

[davidlloyd] 19/3/2020 13:48

What has leaked here i wonder......

DL

[bmnsa] 19/3/2020 13:39

Indeed yes,along with SNG:)

Holding quite a few of each.